PURPOSE: The Cooperative Prostate Cancer Tissue Resource (CPCTR) is a National Cancer Institute-supported tissue bank that provides large numbers of clinically annotated prostate cancer specimens to investigators. This communication describes the CPCTR to investigators interested in obtaining prostate cancer tissue samples. EXPERIMENTAL DESIGN: The CPCTR, through its four participating institutions, has collected specimens and clinical data for prostate cancer cases diagnosed from 1989 onward. These specimens include paraffin blocks and frozen tissue from radical prostatectomy specimens and paraffin blocks from prostate needle biopsies. Standardized histopathological characterization and clinical data extraction are performed for all cases. Information on histopathology, demography (including ethnicity), laboratory data (prostate-specific antigen values), and clinical outcome related to prostate cancer are entered into the CPCTR database for all cases. Materials in the CPCTR are available in multiple tissue formats, including tissue microarray sections, paraffin-embedded tissue sections, serum, and frozen tissue specimens. These are available for research purposes following an application process that is described on the CPCTR web site (www.prostatetissues.org). RESULTS: The CPCTR currently (as of October 2003) contains 5135 prostate cancer cases including 4723 radical prostatectomy cases. Frozen tissues, in some instances including patient serum samples, are available for 1226 cases. Biochemical recurrence data allow identification of cases with residual disease, cases with recurrence, and recurrence-free cases. CONCLUSIONS: The CPCTR offers large numbers of highly characterized prostate cancer tissue specimens, including tissue microarrays, with associated clinical data for biomarker studies. Interested investigators are encouraged to apply for use of this material (www.prostatetissues.org).
PURPOSE: The Cooperative Prostate Cancer Tissue Resource (CPCTR) is a National Cancer Institute-supported tissue bank that provides large numbers of clinically annotated prostate cancer specimens to investigators. This communication describes the CPCTR to investigators interested in obtaining prostate cancer tissue samples. EXPERIMENTAL DESIGN: The CPCTR, through its four participating institutions, has collected specimens and clinical data for prostate cancer cases diagnosed from 1989 onward. These specimens include paraffin blocks and frozen tissue from radical prostatectomy specimens and paraffin blocks from prostate needle biopsies. Standardized histopathological characterization and clinical data extraction are performed for all cases. Information on histopathology, demography (including ethnicity), laboratory data (prostate-specific antigen values), and clinical outcome related to prostate cancer are entered into the CPCTR database for all cases. Materials in the CPCTR are available in multiple tissue formats, including tissue microarray sections, paraffin-embedded tissue sections, serum, and frozen tissue specimens. These are available for research purposes following an application process that is described on the CPCTR web site (www.prostatetissues.org). RESULTS: The CPCTR currently (as of October 2003) contains 5135 prostate cancer cases including 4723 radical prostatectomy cases. Frozen tissues, in some instances including patient serum samples, are available for 1226 cases. Biochemical recurrence data allow identification of cases with residual disease, cases with recurrence, and recurrence-free cases. CONCLUSIONS: The CPCTR offers large numbers of highly characterized prostate cancer tissue specimens, including tissue microarrays, with associated clinical data for biomarker studies. Interested investigators are encouraged to apply for use of this material (www.prostatetissues.org).
Authors: Maarten C Bosland; Ikuko Kato; Anne Zeleniuch-Jacquotte; Joanne Schmoll; Erika Enk Rueter; Jonathan Melamed; Max Xiangtian Kong; Virgilia Macias; Andre Kajdacsy-Balla; L H Lumey; Hui Xie; Weihua Gao; Paul Walden; Herbert Lepor; Samir S Taneja; Carla Randolph; Michael J Schlicht; Hiroko Meserve-Watanabe; Ryan J Deaton; Joanne A Davies Journal: JAMA Date: 2013-07-10 Impact factor: 56.272
Authors: Robyn L Prueitt; Tiffany A Wallace; Sharon A Glynn; Ming Yi; Wei Tang; Jun Luo; Tiffany H Dorsey; Katherine E Stagliano; John W Gillespie; Robert S Hudson; Atsushi Terunuma; Jennifer L Shoe; Diana C Haines; Harris G Yfantis; Misop Han; Damali N Martin; Symone V Jordan; James F Borin; Michael J Naslund; Richard B Alexander; Robert M Stephens; Christopher A Loffredo; Dong H Lee; Nagireddy Putluri; Arun Sreekumar; Arthur A Hurwitz; Stefan Ambs Journal: Cancer Res Date: 2015-12-30 Impact factor: 12.701
Authors: Sumit Isharwal; Michael C Miller; Cameron Marlow; Danil V Makarov; Alan W Partin; Robert W Veltri Journal: Prostate Date: 2008-07-01 Impact factor: 4.104
Authors: Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman Journal: Am J Transl Res Date: 2009-01-01 Impact factor: 4.060
Authors: Rajiv Dhir; Ashok A Patel; Sharon Winters; Michelle Bisceglia; Dennis Swanson; Roger Aamodt; Michael J Becich Journal: Cancer Date: 2008-10-01 Impact factor: 6.860
Authors: Georgios Voidonikolas; Marie-Claude Gingras; Sally Hodges; Amy L McGuire; Changyi Chen; Richard A Gibbs; F Charles Brunicardi; William E Fisher Journal: World J Surg Date: 2009-04 Impact factor: 3.352
Authors: Rebecca S Arnold; Ju He; Andrea Remo; Darren Ritsick; Qiqin Yin-Goen; J David Lambeth; Milton W Datta; Andrew N Young; John A Petros Journal: Am J Pathol Date: 2007-11-30 Impact factor: 4.307
Authors: A Kajdacsy-Balla; J M Geynisman; V Macias; S Setty; N M Nanaji; J J Berman; K Dobbin; J Melamed; X Kong; M Bosland; J Orenstein; J Bayerl; M J Becich; R Dhir; M W Datta Journal: J Mol Histol Date: 2007-02-21 Impact factor: 3.156
Authors: Ashokkumar A Patel; John R Gilbertson; Louise C Showe; Jack W London; Eric Ross; Michael F Ochs; Joseph Carver; Andrea Lazarus; Anil V Parwani; Rajiv Dhir; J Robert Beck; Michael Liebman; Fernando U Garcia; Jeff Prichard; Myra Wilkerson; Ronald B Herberman; Michael J Becich Journal: Cancer Inform Date: 2007-06-08